CAPTRUST Financial Advisors
ANAB icon

CAPTRUST Financial Advisors’s AnaptysBio ANAB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-384
Closed -$8K – 2149
2022
Q2 		$8K Buy
384
+47
+14% +$1.04K ﹤0.01% 3855
2022
Q1 		$8K Hold
337
– – ﹤0.01% 3887
2021
Q4 		$12K Sell
337
-10
-3% -$317 ﹤0.01% 3599
2021
Q3 		$9K Sell
347
-22
-6% -$558 ﹤0.01% 3648
2021
Q2 		$10K Sell
369
-11
-3% -$264 ﹤0.01% 3527
2021
Q1 		$8K Buy
+380
New +$9.59K ﹤0.01% 3524

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

CAPTRUST Financial Advisors's ANAB Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of AnaptysBio (ANAB) in Q3 2022, closing a stake of 384 shares — an estimated $8K sold.

CAPTRUST Financial Advisors first reported a position in ANAB in Q1 2021 and held it in 6 quarters. The position peaked at $12K in Q4 2021. 114 funds tracked by Wall St. Rank hold ANAB as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining AnaptysBio position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 384 AnaptysBio shares in Q3 2022, an estimated $8K.
  • CAPTRUST Financial Advisors first reported a position in AnaptysBio in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's AnaptysBio position peaked at $12K in Q4 2021.
  • 114 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.